Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents [note 7] $ 8,021 $ 15
Amounts receivable 70  
Prepaid expenses 535 3
Total current assets 8,626 18
Restricted cash [note 7 and note 10] 272  
Property and equipment, net 94  
Other assets 415  
License agreement [note 2, 4, 5 and 6] 2,588 2,755
Goodwill [note 2 and 5] 1,034 1,034
Total assets 13,029 3,807
Current liabilities:    
Accounts payable 495 95
Accrued liabilities other 1,297 1,121
Accrued clinical liabilities 162  
Accrued compensation 343 1,028
Stockholder loans with related parties [note 9]   829
Current portion of long-term obligations [note 10] 31  
Warrant liability [note 7 and note 8 [f]] 3  
Total current liabilities 2,331 3,073
Long-term obligations, less current portion [note 10] 16  
Deferred tax liability   124
Total liabilities 2,347 3,197
Commitments and contingencies [note 10]
Stockholders' equity:    
Common stock, $0.001 par value, 75,000,000 shares authorized, 11,491,665 and 21,230 issued at September 30, 2017 and December 31, 2016, respectively, and 11,482,845 and 21,230 outstanding at September 30, 2017 and December 31, 2016, respectively 11  
Additional paid-in capital 19,581 2,667
Accumulated deficit (8,915) (2,062)
Accumulated other comprehensive income 5 5
Total stockholders' equity 10,682 610
Total liabilities and stockholders' equity $ 13,029 $ 3,807